A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses.
Exogenous estrogen use was determined by interview in 206 endometrial cancer patients, 191 women with nonmalignant gynecologic disorders, and 199 women with other illnesses. Separate comparisons of these patients with gynecologic and other illness control subjects provided estimates of the risk of endometrial cancer among estrogen users, adjusted for the effects of confounding variables, of 1.5 (95% confidence limits 0.9 and 2.7) and 4.8 (2.7 and 8.4), respectively. In both comparisons, risk increased with increasing duration of use; regardless of duration of use, risks were higher among users of estrogen within 12 months of diagnosis than among past users. The effects of bias, including surveillance bias, on the results were considered and it was concluded that the true risk was not less than the case/gynecologic control estimate and was likely to approach the case/other control estimate.
D000230:Adenocarcinoma / Q000139:chemically induced; D000328:Adult; D000368:Aged; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D005831:Genital Diseases, Female; D006801:Humans; D008875:Middle Aged; D011159:Population Surveillance; D012306:Risk; D013997:Time Factors; D014594:Uterine Neoplasms / Q000139:chemically induced
D004967:Estrogens